Serum S100 protein as a marker of cerebral damage during cardiac surgery

British Journal of Anaesthesia

Volumn 85, Issue 2, 2000, Pages 287-298

  Shaaban Ali, M ^a   Harmer, M ^a   Vaughan, R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Complications, arrest, cardiac; Surgery, cardiovascular

Indexed keywords

BIOLOGICAL MARKER; HEPARIN; PLASMA PROTEIN; PROTEIN S 100;

ADULT; AGE; AGED; AORTA CLAMPING; AROUSAL; ARTERY CATHETERIZATION; BLOOD FILTRATION; BRAIN INJURY; CARDIOPULMONARY BYPASS; CHILD; CONFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DISEASE MARKER; DISEASE PREDISPOSITION; HEART ARREST; HEART SURGERY; HUMAN; MICROEMBOLISM; NEUROPSYCHOLOGY; NEWBORN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REVIEW; STROKE;

EID: 0033857791     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/85.2.287     Document Type: Review

References (95)

1. Gene encoding subunit of S100 protein is on chromosome 21: Implications for Down syndrome
2. Serum S100β release after coronary artery bypass grafting: Roller versus centrifugal pump
3. Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest
4. Elevated serum levels of S100 protein after deep hypothermic arrest correlate with the duration of circulatory arrest
5. Determination of S100 and glial fibrillary acidic concentrations in cerebrospinal fluid after brain infarction
6. Intraoperative embolus formation during cardiopulmonary bypass affects the release of S100B
7. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium
8. Atheroembolism from the ascending aorta
9. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: A possible marker for cerebral injury
10. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response
11. Left ventricular thrombi seen by ventriculography are significant risk factor for stroke in open-heart surgery
12. Central nervous system complications of coronary artery bypass graft surgery: Prospective analysis of 421 patients
13. Risk factors for stroke in patients undergoing coronary artery bypass grafting
14. S100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction
15. Systemic inflammatory response syndrome after cardiac operations
16. The S100 protein: A protein family in search of a function
17. The S100 protein causes an increase of intracellular calcium and death of PC12 cells
18. Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischemic stroke
19. Extra cellular proteases and S100 protein in long term potentiation in the dentate gyrus of the anaesthetized rat
20. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: Part I - The effects of heparin, protamine and propofol
21. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: Part III- Does haemolysis affect their accuracy?
22. Sangtec 100 release with hypothermic and normothermic bypass
23. Time course of neurone-specific enolase and S100 protein release during and after coronary artery bypass grafting
24. Stroke following coronary artery bypass grafting a ten year study
25. S100 protein in children subjected to cardiopulmonary bypass
26. Effect of MK 801 and U83836E on a porcine brain capillary endothelial cell barrier hypoxia
27. Cardiopulmonary bypass and the blood brain barrier: An experimental study
28. Modifying risk of extracorporeal circulation: Trial of four antiinflammatory strategies
29. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass: Methodological strategies and results of a double-blind, placebo-con
30. Brain interleukin I and S100 protein immunoreactivity are elevated in Down syndrome and Alzheimer disease
31. Cerebral emboli and serum S100β during cardiac operations
32. Serum S100B as a predictor of neurologic and neuropsychologic outcomes after cardiac surgery
33. S-100β stimulates neurite outgrowth in the rat sciatic nerve grafted with a cellular muscle transplants
34. S100 protein and neuron specific enolase in CSF after experimental traumatic or focal ischaemic brain damage
35. Brain swelling in first hour after coronary bypass surgery
36. Cerebral dysfunction after cardiac operations in elderly patients
37. Increased serum concentrations of protein S100 after minor head injury: A biochemical serum marker with prognostic value
38. S100a protein is present in neurons of central and peripheral nervous tissue
39. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats
40. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood
41. Markers of cerebral ischaemia after cardiac surgery
42. Significance of serum S100 release after coronary artery bypass grafting
43. Cerebral injury assessed by S100β protein and neuropsychologic tests after coronary artery bypass surgery
44. Effects of antisera to S100 protein and to synaptic membrane function on maze performance and EEG
45. Neuropsychological change and S100 protein release in 130 unselected patients undergoing cardiac surgery
46. Psychiatric complications of open-heart surgery
47. S-100 protein release in a range of cardiothoracic surgical procedures
48. Serum S100 protein levels after pediatric cardiac operations: A possible new marker for postoperative cerebral injury
49. Risk factors for stroke after coronary artery bypass
50. Defining neuropsychological dysfunction after coronary artery bypass grafting
51. Perioperative stroke encephalopathy and CNS dysfunction
52. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible cerebral ischemia
53. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe
54. Potential role of S100 protein in Alzheimer's disease: An hypothesis involving mitotic protein kinase
55. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats
56. Magnesium protects against neurological deficit after brain injury
57. Predictors of stroke risk in coronary artery bypass patients
58. Hypoxia and reoxygenation of the brain endothelial cells in vitro: A comparison of biological and morphological response
59. Risk factors for cerebral injury and cardiac surgery
60. S100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke
61. A soluble protein characteristic of the nervous system
62. Differential age effects of mean arterial pressure and rewarming on cognitive dysfunction after cardiac surgery
63. Multicentre preoperative stroke risk index for patients undergoing coronary artery bypass surgery
64. Effect of aging on cerebral autoregulation during cardiopulmonary bypass: Association with postoperative cognitive dysfunction
65. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system
66. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning
67. Microemboli and cerebral impairment during cardiac surgery
68. Neurologic injury in cardiac surgical patients with a history of stroke
69. Adverse cerebral outcomes after coronary bypass surgery
70. Increased serum levels of the S100 protein are associated with hypoxic brain damage after cardiac arrest
71. Cerebrospinal fluid: Blood-brain barrier, brain edema, and hydrocephalus
72. Central nervous system damage following cardiopulmonary bypass surgery: A retrospective analysis of 1386 cases
73. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: Part II - Must samples be spun within 30 min
74. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: Background and study protocol
75. Neurotrophic protein S100β stimulates glial cell proliferation
76. Early neurological complications of coronary artery bypass surgery
77. Energy equivalent pressure
78. Stroke during coronary bypass grafting using hypothermic versus normothermic perfusion
79. Etiologic factors in neuropsychiatric complications associated with cardiopulmonary bypass
80. Glial cytokines as neuropathogenic factors in HIV infection: Pathogenic similarities to Alzheimer's disease
81. The effect of age on neurologic outcome after cardiac surgery
82. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia
83. Clinical effects of heparin coated surface in cardiopulmonary bypass
84. Serum S100 protein concentration after cardiac surgery: A randomized trial of arterial line filtration
85. Comparison of serum S100 beta levels during coronary artery bypass grafting and intracardiac operations
86. Magnetic resonance imaging and neuropsychological changes after coronary bypass graft surgery: Preliminary findings
87. Comparison of S100 protein release during normothermic and mild hypothermic cardiopulmonary bypass
88. Differential effects of advanced age on neurologic and cardiac risks of coronary artery operations
89. S100a0 protein in blood and urine during open-heart surgery
90. Neuropsychological function in patients with increased serum levels of protein S100 after minor head injury
91. Serum S100 protein, a potential marker for cerebral events during cardiopulmonary bypass
92. Cerebral injury after cardiac surgery; identification of a group at extraordinary risk
93. The S100 protein family: History, function, and expression